ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug BR111 enters first human trial
Disease control Recruiting nowThis early-stage study tests a new drug called BR111 in 166 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and to see if the drug can shrink tumors. Participants receive the drug every three weeks, and …
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
New cancer drug BRY812 enters first human trials
Disease control Recruiting nowThis early-stage study tests a new drug, BRY812, in people with advanced solid tumors that no longer respond to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants receive the drug every three weeks…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called BI-1808, alone or with another drug (pembrolizumab), in people with advanced cancers (like ovarian cancer, melanoma, or T-cell lymphoma) that have not responded to standard treatments. The main goals are to check safety, find the bes…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 13, 2026 15:59 UTC